---
$id: https://graph.org.ai/products/commodity/51182024
$type: Product
source: UNSPSC
code: "51182024"
title: "Danazol"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Danazol

**UNSPSC Code**: 51182024
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen, gonadotropin releasing hormone inhibitor, and anabolic steroid with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N29QWW3BUO, chemically known as win 17,757 but generally known as danazol, which bears US NIH Compound Identifier 2949. European Medicines Agency schedules Danazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06897MIG. The term DANAZOL is an International Non-Proprietary Name. World Health Organization schedules danazol in its Anatomical Therapeutic Chemical (ATC) Classification. DANAZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule danazol under HS 29372900 and SITC 54153. As of Q4 2014, DANAZOL remains the US FDA Preferred Term for this commodity. Danazol bears US NLM identifiers UMLS ID C0010961 and NCI Concept Code C414. SMILES: OC1(C2(C(C3C(C4(C(=CC5ONCC5C4)CC3)C)CC2)CC1)C)C#C.

